Reported Jul 20, 2026 · Announced · Updated Sep 17, 2026

Unique Pharmaceutical Laboratories recalls Rising Pharma Holdings Inc. Cetirizine Hydrochloride Tablets USP 5 mg due to Potential cross contamination with…

Unique Pharmaceutical Laboratories

Risk not classifiedThe agency has not ranked the risk yet — treat the notice as a caution.

What you should do

Stop using the product and follow the return or refund instructions in the firm's announcement.

What it looks like

  • Recalled product from Unique Pharmaceutical Laboratories
  • Recalled product from Unique Pharmaceutical Laboratories
  • Recalled product from Unique Pharmaceutical Laboratories

Is this the product you have?

  • Cetirizine
  • Hydrochloride Tablets USP 5 mg BrandRising Pharma Holdings Inc.. Drugs

Why it was recalled

Potential cross contamination with Ranitidine

The agency has not ranked the risk yet — treat the notice as a caution.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Unique Pharmaceutical Laboratories recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration

Read the FDA (recalls & safety alerts) notice

Data as of Sep 19, 4:19 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.